Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients

(2016) Hamid Emadi-Kouchak et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial

(2016) Ali Ghaleiha et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study

(2016) Sahra Emamzadehfard et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

DNA damage and antioxidants in treatment naïve children with obsessive–compulsive disorder

(2016) Şeref Şimşek et al.   PSYCHIATRY RESEARCH

Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

(2015) Christopher Pittenger et al.   JOURNAL OF CLINICAL PSYCHIATRY

Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial

(2015) M. Shalbafan et al.   PHARMACOPSYCHIATRY

Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder

(2015) Demet Alici et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder

(2014) Mahnaz Heidari et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study

(2014) Mohammad-Reza Khodaie-Ardakani et al.   PSYCHIATRY RESEARCH

12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive–Compulsive Disorder

(2013) Paul J Grant et al.   NEUROPSYCHOPHARMACOLOGY

In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

(2013) Mohammad Haghighi et al.   PSYCHOPHARMACOLOGY

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder

(2012) Neda Askari et al.   CNS DRUGS

Minocycline

(2012) Olivia M. Dean et al.   CNS DRUGS

Obsessive–compulsive disorders

(2012) Per Hove Thomsen   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study

(2012) Ali Ghaleiha et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment

(2011) Christopher Pittenger et al.   PHARMACOLOGY & THERAPEUTICS

The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder

(2011) Ke Wu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse

(2011) Marianne Güldenpfennig et al.   PHYSIOLOGY & BEHAVIOR

Minocycline Augmentation of Pharmacotherapy in Obsessive-Compulsive Disorder

(2010) Carolyn I. Rodriguez et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder

(2010) S. Evelyn Stewart et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice

(2010) Felipe V. Gomes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Clinical predictors of health-related quality of life in obsessive-compulsive disorder

(2009) Umberto Albert et al.   COMPREHENSIVE PSYCHIATRY

Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

(2009) Elias Aboujaoude et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Effects of agents targeting glutamatergic systems on marble-burying behavior

(2009) Michihiko Iijima et al.   NEUROSCIENCE LETTERS